International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers

Article Information

Volume / Issue6 / 2 (April-June 2025)
Pages61-66
AccessOpen Access

Publication Timeline

  • Received03 February 2025
  • Accepted05 March 2025

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Early diagnosis of neurodegenerative diseases (NDs) such as Alzheimer’s (AD) and Parkinson’s (PD) is critically dependent on detecting specific protein biomarkers at very low concentrations. This study presents the design, fabrication, and characterization of a novel label-free electrochemical biosensor for ultrasensitive detection of key ND biomarkers (β-amyloid (Aβ), tau, and α-synuclein). A glassy carbon electrode (GCE) was modified with a nanocomposite of carboxyl graphene (CG), thionin, and electrodeposited Au nanoparticles (AuNPs) to immobilize a specific aptamer against tau protein. Electrochemical techniques (cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS)) were used to verify each modification step, and differential pulse voltammetry (DPV) was used to measure biomarker binding. The sensor yielded a linear response from 0.5 pM to 100 pM tau₃₈₁, with a detection limit (LOD) of ~0.5 pM and high sensitivity. These performance metrics are comparable to or exceed those of previously reported label-free biosensors. Cross-reactivity tests showed excellent selectivity against non-target proteins. The fabricated biosensor demonstrates rapid, reproducible detection of tau at clinically relevant levels, addressing key research questions: (1) Can a label-free electrochemical biosensor be engineered to detect neurodegenerative biomarkers at ultra-low concentrations? (2) What sensitivity and specificity can be achieved through nanomaterial-enhanced signal transduction? (3) How does this sensor performance compare with existing biosensing platforms? In answering these questions, this work contributes to the development of point-of-care ND diagnostics.

References

  1. Rushworth JV, Ahmed AS, Griffiths HH, Pollock NM, Hooper NM, Millner PA. A label-free electrical impedimetric biosensor for the specific detection of Alzheimer’s amyloid-beta oligomers. Biosens Bioelectron.2014;56:83–90. [Google Scholar][Crossref]
  2. Kaushik A, Shah P, Vabbina PK, Jayant RD, Tiwari S, Vashist A, Nair M. A label-free electrochemical immunosensor for beta-amyloid detection. Anal Methods. 2016;8:6115–6120. [Google Scholar][Crossref]
  3. Tao D, Shui B, Gu Y, Cheng J, Zhang W, Jaffrezic-Renault N, Song S, Guo Z. Development of a label-free electrochemical aptasensor for the detection of tau381 and its preliminary application in AD and non-AD patients’ sera. Biosensors (Basel). 2019;9(3):84. [Google Scholar][Crossref]
  4. Ricci S, Casalini S, Parkula V, Selvaraj M, Saygin GD, Greco P, et al. Label-free immunodetection of α-synuclein by using a microfluidics coplanar electrolyte-gated organic field-effect transistor. Biosens Bioelectron.2020;167:112433. [Google Scholar][Crossref]
  5. Carneiro P, Loureiro JA, Delerue-Matos C, Morais S, Pereira MC. Nanostructured label-free electrochemical immunosensor for detection of a Parkinson’s disease biomarker. Talanta. 2023;252:123838. [Google Scholar][Crossref]
  6. Li M, Zeng Y, Huang Z, Zhang L, Liu Y. Vertical graphene-based printed electrochemical biosensor for simultaneous detection of four Alzheimer’s disease blood biomarkers. Biosensors (Basel). 2023;13(8):758. [Google Scholar][Crossref]
  7. Bae M, Kim N, Cho E, Lee T, Lee JH. Recent advances in electrochemical biosensors for neurodegenerative disease biomarkers. Biosensors (Basel). 2025;15(3):151. [Google Scholar][Crossref]
  8. Wang J, Lu X, He Y. Electrochemical technology for the detection of tau proteins as a biomarker of Alzheimer’s disease in blood. Biosensors (Basel). 2025;15(2):85. [Google Scholar][Crossref]

How to Cite

Olukotun, I. F., Titus-Okpanachi, A. O., Tiamiyu, R. T., & Inegbedion, E. (2025). Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers. International Journal of Medical and All Body Health Research, 6(2), 61-66. https://doi.org/10.54660/IJMBHR.2025.6.2.61-66

Olukotun, Ibukunoluwa Fikayo, et al. "Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers." International Journal of Medical and All Body Health Research, vol. 6, no. 2, 2025, pp. 61-66. https://doi.org/10.54660/IJMBHR.2025.6.2.61-66.

Olukotun, I. F., Titus-Okpanachi, A. O., Tiamiyu, R. T. and Inegbedion, E. (2025) 'Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers', International Journal of Medical and All Body Health Research, 6(2), pp. 61-66. doi: 10.54660/IJMBHR.2025.6.2.61-66.

Olukotun IF, Titus-Okpanachi AO, Tiamiyu RT, Inegbedion E. Development of a Label-Free Electrochemical Biosensor for Early Detection of Neurodegenerative Disease Biomarkers. International Journal of Medical and All Body Health Research. 2025;6(2):61-66. doi:10.54660/IJMBHR.2025.6.2.61-66

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.